Low calcium diet in hypercalciuric calcium nephrolithiasis: first do no harm
- PMID: 9813631
Low calcium diet in hypercalciuric calcium nephrolithiasis: first do no harm
Abstract
Many studies indicate that up-regulated production of 1,25(OH)2-vitamin D3 (calcitriol) with increased intestinal absorption of calcium is the primary event causing idiopathic hypercalciuria. Thus, a low calcium diet appears to be a straightforward strategy in calcium stone formers with hypercalciuria (HCSF). However, the efficacy of such a regimen has never been established, and lowering calcium intake from 1000 to 400 mg/day further enhances calcitriol production. On a diet chronically restricted in calcium, many stone formers increase their intake of animal flesh protein. The latter is known to increase renal mass, and calcitriol levels indeed are positively correlated with renal mass in animals as well as in HCSF. Thus, low calcium and high animal flesh protein consumption are independent stimuli for further up-regulation of calcitriol production. The rise in calcitriol suppresses parathyroid hormone synthesis thereby diminishing renal tubular calcium reabsorption, and increasing urinary calcium losses. Since calcitriol up-regulation also increases bone resorption, the combination of low calcium and high protein intake is particularly likely to induce negative calcium balance and thus osteopenia. Finally, low calcium intake carries the risk of insufficient intestinal binding of oxalate with subsequent increases in intestinal absorption and urinary excretion of oxalate. Indeed, most recent studies suggest that high amounts of calcium, when ingested simultaneously with oxalate-containing meals, are able to prevent hyperoxaluria during severe oral oxalate loading.
Similar articles
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
-
Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.Scand J Urol Nephrol Suppl. 1989;119:1-53. Scand J Urol Nephrol Suppl. 1989. PMID: 2669121 Review.
-
[Diagnostic markers in calcium nephrolithiasis--current and traditional ideas with a new look].Schweiz Med Wochenschr. 1995 Dec 26;125(51-52):2460-70. Schweiz Med Wochenschr. 1995. PMID: 8571096 Review. German.
-
Diet and renal stone formation.Minerva Med. 2013 Feb;104(1):41-54. Minerva Med. 2013. PMID: 23392537
-
Possible link between vitamin D and hyperoxaluria in patients with renal stone disease.Clin Sci (Lond). 1993 Jan;84(1):51-4. doi: 10.1042/cs0840051. Clin Sci (Lond). 1993. PMID: 8382134
Cited by
-
Alpha-enolase on apical surface of renal tubular epithelial cells serves as a calcium oxalate crystal receptor.Sci Rep. 2016 Oct 31;6:36103. doi: 10.1038/srep36103. Sci Rep. 2016. PMID: 27796334 Free PMC article.
-
Bone disease in primary hypercalciuria.Clin Cases Miner Bone Metab. 2008 May;5(2):118-26. Clin Cases Miner Bone Metab. 2008. PMID: 22460993 Free PMC article.
-
Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects.Urol Res. 2010 Jun;38(3):169-78. doi: 10.1007/s00240-010-0262-9. Epub 2010 Mar 12. Urol Res. 2010. PMID: 20224931 Clinical Trial.
-
Dietary treatment of nephrolithiasis.Clin Cases Miner Bone Metab. 2008 May;5(2):135-41. Clin Cases Miner Bone Metab. 2008. PMID: 22460996 Free PMC article.
-
ACP Best Practice No 181: Chemical pathology clinical investigation and management of nephrolithiasis.J Clin Pathol. 2005 Feb;58(2):134-40. doi: 10.1136/jcp.2004.019588. J Clin Pathol. 2005. PMID: 15677531 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical